RADIATION DOSE TO ORGANS AT RISK AFTER HIGH DOSE RATE BRACHYTHERAPY FOR ESOPHAGEAL CANCER PATIENTS

被引：0
|
作者：
Darvish-Molla, Sahar [1 ]
Timotin, Emilia [1 ]
Skoczny, Jack [1 ]
Farrell, Thomas [1 ]
Sur, Ranjan K. [2 ]
机构：
[1] Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 150卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Mucosal Dose Constraints for Endoluminal High Dose Rate Brachytherapy for Esophageal Cancer
    Thawani, N.
    Morrow, A.
    Patel, S.
    Srivastava, S. P.
    Pinnaduwage, D.
    Jani, S.
    Sorensen, S. P.
    Ellefson, S. T.
    Mutyala, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E12 - E13
  • [2] RADIATION-THERAPY OF ESOPHAGEAL CANCER - ROLE OF HIGH-DOSE RATE BRACHYTHERAPY
    SUR, RK
    SINGH, DP
    SHARMA, SC
    SINGH, MT
    KOCHHAR, R
    NEGI, PS
    SETHI, T
    PATEL, F
    AYYAGARI, S
    BHATIA, SPS
    GUPTA, BD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05): : 1043 - 1046
  • [3] Effects of Interfraction Dose Variations of Target and Organs at Risk on Clinical Outcomes in High Dose Rate Brachytherapy for Cervical Cancer
    Washington, Brien
    Cheek, Dennis
    Fabian, Denise
    Kudrimoti, Mahesh
    Pokhrel, Damodar
    Wang, Chi
    Thayer-Freeman, Cameron
    Luo, Wei
    CANCERS, 2023, 15 (19)
  • [4] Support Vector Machine Model Predicts Dose for Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer
    Zhou, Ping
    Li, Xiaojie
    Zhou, Hao
    Fu, Xiao
    Liu, Bo
    Zhang, Yu
    Lin, Sheng
    Pang, Haowen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] RISK OF SECONDARY BLADDER CANCER AFTER HIGH DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER
    Miyaji, Yoshiyuki
    Nakatsuk, Tota
    Takasaki, Hiroyasu
    Kin, Seitetsu
    Ohira, Shin
    Fujita, Masaichiro
    Shimizu, Shinjiro
    Tsukimori, Shohei
    Kaifu, Mikako
    Hara, Ryoei
    Fujii, Tomohiro
    Nagai, Atsushi
    JOURNAL OF UROLOGY, 2018, 199 (04): : E279 - E280
  • [6] High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer
    Nonoshita T.
    Sasaki T.
    Hirata H.
    Toh Y.
    Shioyama Y.
    Nakamura K.
    Honda H.
    Radiation Medicine, 2007, 25 (8): : 373 - 377
  • [7] SALVAGE HIGH-DOSE-RATE BRACHYTHERAPY FOR RECURRENT ESOPHAGEAL CANCER
    Kam, S. Wong Hee
    Quero, L.
    Rivera, S.
    Michaud, S.
    Maylin, C.
    Hennequin, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S369 - S369
  • [8] HIGH-DOSE-RATE INTRALUMINAL BRACHYTHERAPY (HDRIBT) FOR ESOPHAGEAL CANCER
    HISHIKAWA, Y
    KURISU, K
    TANIGUCHI, M
    KAMIKONYA, N
    MIURA, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (05): : 1133 - 1135
  • [9] Salvage High Dose Rate Brachytherapy for Recurrent Prostate Cancer after Definitive Radiation
    Wu, S. Y.
    Wong, A. C.
    Shinohara, K.
    Chang, A. J.
    Roach, M., III
    Hsu, I. C. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S134 - S135
  • [10] Influence of Bladder Volume on the Dose to the Target and Organs at Risk in High Dose Rate Intracavitary Brachytherapy of Cervix
    Ramya Rangarajan
    S. Saravanan
    K. Kumari
    Indian Journal of Gynecologic Oncology, 2022, 20
12345